Follow us on LinkedIn
Pharmacovigilance
NTC
Novelty, Technology, Care
NTC at CPhI - Frankfurt 2019 - Stand 91B71
- Nov 05, 2019
CPhI Worldwide, 5-7 November 2019.
See you in Frankfurt.
Lertal® significantly favors good functioning of the immune system
- Sept 03, 2019
Lertal® significantly favors good functioning of the immune system the immune system’s activity and improves the management of rhinoconjunctivitis in children.
NTC ACQUIRES FROM NMTECH UK TiAb AND SIAB BASED TECHNOLOGY
- June 12, 2019
Milan, Italy, June 12, 2019 – NTC focuses on strengthening its gynecology, dermatology and ophthalmology portfolio and pipeline.
NEW LIFE FOR PATIENTS SUFFERING FROM BLEPHARITIS: a controlled clinical study was presented on Blefastop, an ocular and periocular innovative therapeutic solution as adjuvant in blepharitis.
- June 5, 2019
Milan, June 5, 2019 – Recently, a controlled clinical study was presented on Blefastop, an ocular and periocular innovative therapeutic solution as adjuvant in blepharitis.